Circulating mesenchymal stem cells and their clinical implications

Journal of Orthopaedic Translation

Volumn 2, Issue 1, 2014, Pages 1-7

  Xu, Liangliang ^a   Li, Gang ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allogenic MSCs; Cell therapy; Circulating MSCs

Indexed keywords

ALPHA4 INTEGRIN; BONE MORPHOGENETIC PROTEIN 2; CHEMOKINE RECEPTOR CCR4; FIBROBLAST GROWTH FACTOR 2; P SELECTIN GLYCOPROTEIN LIGAND 1; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A;

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CARDIOVASCULAR DISEASE; CARTILAGE; CELL HOMING; CELL MIGRATION; CELL THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE; MESENCHYMAL STEM CELL; NONHUMAN; REVIEW; SPINAL CORD INJURY; STEM CELL MOBILIZATION; TISSUE REGENERATION; TISSUE REPAIR;

EID: 84921509561     PISSN: 2214031X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jot.2013.11.002     Document Type: Review

References (60)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Jiang Y.H., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
3. Tse W.T., Beyer W., Pendleton J.D., D'Andrea A., Guinan E.C. Bone marrow derived mesenchymal stem cells suppress T cell activation without inducing allogeneic anergy. Blood 2000, 96:241a.
4. Paul J. Establishment of permanent cell strains from human adult peripheral blood. Nature 1958, 182:808.
5. Luria E.A., Panasyuk A.F., Friedenstein A.Y. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 1971, 11:345-349.
6. Bian Z.Y., Li G., Gan Y.K., Hao Y.Q., Xu W.T., Tang T.T. Increased number of mesenchymal stem cell-like cells in peripheral blood of patients with bone sarcomas. Arch Med Res 2009, 40:163-168.
7. Lan Y., Kodati S., Lee H.S., Omoto M., Jin Y., Chauhan S.K. Kinetics and function of mesenchymal stem cells in corneal injury. Invest Ophthalmol Vis Sci 2012, 53:3638-3644.
8. He Q., Wan C., Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 2007, 25:69-77.
9. Castromalaspina H., Gay R.E., Resnick G., Kapoor N., Meyers P., Chiarieri D., et al. Characterization of human-bone marrow fibroblast colony-forming cells (Cfu-F) and their progeny. Blood 1980, 56:289-301.
10. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J Cell Biol 2001, 153:1133-1140.
11. Fernandez M., Simon V., Herrera G., Cao C., Del Favero H., Minguell J.J. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transpl 1997, 20:265-271.
12. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., Edwards C.J., Moss J., Burger J.A., et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000, 2:477-488.
13. Elfenbein G.J., Sackstein R. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 2004, 32:327-339.
14. Brooke G., Tong H., Levesque J.P., Atkinson K. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 2008, 17:929-940.
15. Kollar K., Cook M.M., Atkinson K., Brooke G. Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol 2009, 2009:904682.
16. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
17. Li Y., Yu X., Lin S., Li X., Zhang S., Song Y.H. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 2007, 356:780-784.
18. Song C., Li G. CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors. Cytotherapy 2011, 13:549-561.
19. Ruster B., Gottig S., Ludwig R.J., Bistrian R., Muller S., Seifried E., et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006, 108:3938-3944.
20. Sackstein R., Merzaban J.S., Cain D.W., Dagia N.M., Spencer J.A., Lin C.P., et al. Exvivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 2008, 14:181-187.
21. Shi M., Li J., Liao L., Chen B., Li B., Chen L., et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007, 92:897-904.
22. Tsai L.K., Leng Y., Wang Z.F., Leeds P., Chuang D.M. The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms. Neuropsychopharmacol 2010, 35:2225-2237.
23. Cheng Z., Ou L., Zhou X., Li F., Jia X., Zhang Y., et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008, 16:571-579.
24. Saito T., Kuang J.Q., Bittira B., Al-Khaldi A., Chiu R.C. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002, 74:19-24. discussion 24.
25. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003, 361:45-46.
26. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S.M., Mukhachev V., Lavroukov A., et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. New Engl J Med 2001, 344:385-386.
27. Solchaga L.A., Gao J.Z., Dennis J.E., Awadallah A., Lundberg M., Caplan A.I., et al. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 2002, 8:333-347.
28. Murphy J.M., Fink D.J., Hunziker E.B., Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003, 48:3464-3474.
29. Granero-Molto F., Weis J.A., Miga M.I., Landis B., Myers T.J., O'Rear L., et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 2009, 27:1887-1898.
30. Li Z.H., Liao W., Cui X.L., Zhao Q., Liu M., Chen Y.H., et al. Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head. Int J Med Sci 2011, 8:74-83.
31. Wan C., He Q., Li G. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 2006, 24:610-618.
32. Nasir G.A., Mohsin S., Khan M., Shams S., Ali G., Khan S.N., et al. Mesenchymal stem cells and interleukin-6 attenuate liver fibrosis in mice. J Transl Med 2013, 11:78.
33. Kumar S., Nagy T.R., Ponnazhagan S. Therapeutic potential of genetically modified adult stem cells for osteopenia. Gene Ther 2010, 17:105-116.
34. Alm J.J., Koivu H.M., Heino T.J., Hentunen T.A., Laitinen S., Aro H.T. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res 2010, 28:1634-1642.
35. Mansilla E., Marin G.H., Drago H., Sturla F., Salas E., Gardiner C., et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transpl Proc 2006, 38:967-969.
36. Dalle Carbonare L., Valenti M.T., Zanatta M., Donatelli L., Lo Cascio V. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 2009, 60:3356-3365.
37. Shirley D., Marsh D., Jordan G., McQuaid S., Li G. Systemic recruitment of osteoblastic cells in fracture healing. J Orthop Res 2005, 23:1013-1021.
38. Wang Y., Johnsen H.E., Mortensen S., Bindslev L., Ripa R.S., Haack-Sorensen M., et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006, 92:768-774.
39. Aicher A., Zeiher A.M., Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005, 45:321-325.
40. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
41. Paganessi L.A., Walker A.L., Tan L.L., Holmes I., Rich E., Fung H.C., et al. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis. Exp Hematol 2011, 39:384-390.
42. Kassis I., Zangi L., Rivkin R., Levdansky L., Samuel S., Marx G., et al. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transpl 2006, 37:967-976.
43. Iwasaki M., Koyanagi M., Kossmann H., Monsefi N., Rupp S., Trauth J., et al. Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblasts. Eur Heart J 2011, 32:627-636.
44. Zhuo Y., Li S.H., Chen M.S., Wu J., Kinkaid H.Y., Fazel S., et al. Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. J Thorac Cardiovasc Surg 2010, 139:1286-1294.
45. Kinkaid H.Y., Huang X.P., Li R.K., Weisel R.D. What's new in cardiac cell therapy? Allogeneic bone marrow stromal cells as "universal donor cells". J Card Surg 2010, 25:359-366.
46. Hare J.M., Fishman J.E., Gerstenblith G., DiFede Velazquez D.L., Zambrano J.P., Suncion V.Y., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
47. Xu J., Wang D., Liu D., Fan Z., Zhang H., Liu O., et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood 2012, 120:3142-3151.
48. Wang D., Zhang H., Cao M., Tang Y., Liang J., Feng X., et al. Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis 2011, 70:1285-1288.
49. Tsuchida H., Hashimoto J., Crawford E., Manske P., Lou J. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res 2003, 21:44-53.
50. Ichim T.E., Solano F., Lara F., Paris E., Ugalde F., Rodriguez J.P., et al. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med 2010, 3:30.
51. Planka L., Gal P., Kecova H., Klima J., Hlucilova J., Filova E., et al. Allogeneic and autogenous transplantations of MSCs in treatment of the physeal bone bridge in rabbits. BMC Biotechnol 2008, 8:70.
52. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002, 99:8932-8937.
53. Houtgraaf J.H., de Jong R., Kazemi K., de Groot D., van der Spoel T.I., Arslan F., et al. Intracoronary infusion of allogeneic mesenchymal precursor cells directly following experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling and improves cardiac function. Circ Res 2013, 113:153-166.
54. Liang J., Zhang H., Hua B., Wang H., Wang J., Han Z., et al. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 2009, 15:644-646.
55. Wang D., Zhang H., Liang J., Li X., Feng X., Wang H., et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years experience. Cell Transpl 2012, [Epub ahead of print] http://dx.doi.org/10.3727/096368912X658719.
56. Nakamura T., Sekiya I., Muneta T., Hatsushika D., Horie M., Tsuji K., et al. Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs. Cytotherapy 2012, 14:327-338.
57. Ishikane S., Yamahara K., Sada M., Harada K., Kodama M., Ishibashi-Ueda H., et al. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. J Mol Cell Cardiol 2010, 49:753-761.
58. Conget P., Rodriguez F., Kramer S., Allers C., Simon V., Palisson F., et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010, 12:429-431.
59. Lazebnik L.B., Kniazev O.V., Konopliannikov A.G., Parfenov A.I., Ruchkina I.N., Mikhailova Z.F., et al. Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation. Eksp Klin Gastroenterol 2010, 3-15. [Article in Russian].
60. Togel F., Cohen A., Zhang P., Yang Y., Hu Z., Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2009, 18:475-485.